Clinical Trials Browser

Withdrawn × Recurrence × ixazomib × Clear all

NCT06050512 2024-11-19

Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma

Phase 1/2 Withdrawn

Multiple Myeloma, Recurrence

NCT02578121 2017-01-23

UARK 2015-03 A Phase II Trial of a Novel Proteasome/IMiD Combination

Phase 2 Withdrawn

Multiple Myeloma, Recurrence